Microbix Biosystems Inc.
MBXBF
$0.19
-$0.01-6.41%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.43M | 3.03M | 2.72M | 2.51M | 3.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.43M | 3.03M | 2.72M | 2.51M | 3.71M |
| Cost of Revenue | 1.26M | 1.78M | 1.62M | 1.49M | 1.50M |
| Gross Profit | 1.17M | 1.24M | 1.10M | 1.02M | 2.21M |
| SG&A Expenses | 1.65M | 1.52M | 1.67M | 1.56M | 1.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.34M | 3.71M | 3.74M | 3.47M | 3.50M |
| Operating Income | -907.70K | -680.90K | -1.02M | -961.00K | 207.10K |
| Income Before Tax | -1.03M | -837.20K | -1.12M | -1.19M | 14.40K |
| Income Tax Expenses | -- | -- | -40.50K | -- | -- |
| Earnings from Continuing Operations | -1.03M | -837.20K | -1.08M | -1.19M | 14.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.03M | -837.20K | -1.08M | -1.19M | 14.40K |
| EBIT | -907.70K | -680.90K | -1.02M | -961.00K | 207.10K |
| EBITDA | -574.40K | -425.20K | -752.00K | -639.50K | 505.40K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 138.67M | 139.05M | 136.22M | 140.58M | 139.85M |
| Average Diluted Shares Outstanding | 138.72M | 139.05M | 136.22M | 140.61M | 140.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |